The cation-complexing carboxylic-acid antibiotic X-537A, at concentrations far below that required for ionophorous activity, selectively inhibits the oxidation of glutamate and isocitrate by liver mitochondria in steady-state 3. The site of inhibition has been localized specifically at the reduction of NADP+. Glutamate and isocitrate dehydrogenases, the oxidation of NAD+.dependent substrates, pyridine nucleotide transhydrogenations, and the respiratory chain between NADH (or NADPH) and 02 are unaffected by the antibiotic X-537A. Kinetic evidence, i.e., competition between chlorotetracycline (a fluorescence probe for membranebound bivalent cation) and X-537A, indicates that the NADP+-reducing, antibiotic-sensitive site is most probably associated with the inner mitochondrial membrane.
The cation-binding carboxylic-acid antibiotic X-537A (see formula in Fig. 1 ) was found to inhibit phosphorylative respiration of liver mitochondria with glutamate as substrate at concentrations that were about two orders of magnitude lower than required for the induction of the efflux of Mg2+ and Ca2+ (1) . It was concluded from these studies that the inhibitory site of low concentrations of X-537A is most probably localized in the inner mitochondrial membrane, and that this site may contain a membrane-bound bivalent cation. The participation of a membrane-bound site for bivalent cations in mitochondrial electron transfer has hitherto not been considered. For this reason, we extended our previous work in order to ascertain the existence and function of this postulated regulatory system. The experiments reported in the present communication demonstrate that the antibiotic-sensitive inhibitory site is specifically concerned with the reduction of NADP+ by either glutamate or isocitrate. It is shown, furthermore, that in coupled mitochondria, glutamate and isocitrate reduce mitochondrial NADP+, hence the inhibitory action of X-537A is restricted to the oxidation of these two cellular substrates. The antibiotic-sensitive mitochondrial site represents a specific, hitherto unrecognized, inhibitory or potentially regulatory system of mitochondrial electron transfer. Discovery of this site opens the possibility of the further exploration of the cellular biochemical significance of this antibiotic-sensitive membrane system.
MATERIALS AND METHODS
Rat-liver mitochondria were isolated according to Schnaitman and Greenawalt (2) from male Sprague-Dawley rats (200 g) which were starved for 18 hr before the experiments. The specific inhibitor of glutamate: oxalacetate aminotransferase, a,a'-difluoro-oxalacetic acid (F2OAA) (3) , was synthesized by a described method (4) . NAD+, NADP+, and mitochondrial substrates were commercial products of highest purity. The antibiotic X-537A was a gift from Dr. J. Berger (Hoffman La Roche Co., N.J.). Mitochondrial 02 uptake was recorded in a Gilson recording polarograph. The reaction chamber (1.4-ml volume) was kept at 30°by a surrounding water jacket. The fluorometric assay for membrane-bound bivalent cations was carried out according to Caswell and Hutchinson (5) . Fluorometric analyses for NAD+ and NADP+ were performed in perchloric-acid filtrates according to Estabrook and Maitra (6) . For insensitive, is inhibited by X-537A to the same extent as the predominantly oxidative metabolism of glutamate by fresh mitochondria (the median inhibitory dose of X-537A is 20-50 pmol/mg of mitochondrial protein).
Since the specificity of the inhibitory effect of X-537A was restricted to the oxidation of glutamate and isocitrate under state-3 conditions, the nature of this inhibition was studied in detail. As shown in Fig. 2 , the dose-response relationship between the concentration of the antibiotic and its effect on glutamate or isocitrate oxidation was found to be identical. A comparison of the effects of X-537A on 02 uptake and on the redox state of intramitochondrial pyridine nucleotides during state 4 -.o 3 transition is illustrated in Fig. 3 . As expected, addition of ADP causes a rapid change of the redox state of pyridine nucleotides from a more reduced to a more oxidized (Fig. 3A) form, coincident with a large increase in the rate of 02 uptake. In the presence of inhibitory concentrations of the antibiotic, despite the inhibited respiration, the oxidized form of pyridine nucleotides was significantly increased (Fig. 3B ). These changes in the redox state of pyridine nucleotides indicate that the inhibitory site of X-537A was not in the electron-transfer chain between NADH or NADPH and 02 but rather on the substrate side of pyridine nucleotides. In agreement with this conclusion, neither the oxidation of NADH or NADPH nor transhydrogenations between pyridine nucleotides, both reactions catalyzed by submitochondrial particles (prepared by sonication), were affected by X-537A. Since neither glutamate nor isocitrate dehydrogenases were inhibited by the antibiotic, it was apparent that the inhibitory effect of X-537A had to be at the site of the reduction of either NAD+ or NADP+ (i.e., between the primary dehydrogenase and the electron-transfer system of the inner membrane). The mode of inhibition by X-537A was studied by direct kinetic analysis of both mitochondrial pyridine nucleotides. First, mitochondrial reduced pyridine nucleotides were allowed to be oxidized in the presence of ADP + Pi for 3 min; thereafter, specific substrates were added together with rotenone to inhibit electron transfer to 02. In order to minimize the interference of the transminative pathway of glutamate with the oxidative path, F20AA was added in one series. The following conclusions can be drawn fiom the experiments shown in Fig. 4 hibited by X-537A ( Fig. 4a and b) . When transaminase was inhibited by F20AA, only NADP+ was reduced by glutamate, and again this reduction was inhibited by the antibiotic (Fig.  4c) . In contrast, the rates of reduction of pyridine nucleotides by g-hydroxybutyrate were not significantly affected by X-537A (Fig. 4d) .
According to previous results (1), the inhibition of glutamate oxidation by X-537A coincided with the quenching of chlorotetracycline fluorescence. Since this fluorescence probe is indicative of membrane-bound bivalent cations (5), a competitive relationship between the antibiotic X-537A and fluorescence (of chlorotetracycline) may indicate that the antibiotic binds to the same membrane site as the fluorescence probe. As illustrated in a typical Dixon plot (Fig. 5) , there is indeed a competition between X-537A and chlorotetracycline. DISCUSSION The mode of action of X-537A indicates the existence of an unusual inhibitory site in mitochondrial electron transfer. Operation of this site depends on intact mitochondrial structure and function; thus it is a characteristic property of the organelle. No effect of X-537A on submitochondrial particles could be observed. As deduced from previous experiments (1), and further supported by the competitive kinetics between X-537A and the bivalent-cation complexing chlorotetracycline probe, an inner membrane-bound bivalent cation (probably Mg2+) is a likely inhibitory site. Whereas the nature of this new membrane site is as yet unknown, the consequence of its inhibition by X-537A can be analyzed with greater precision. The inhibition by X-537A occurs at the pyridine nucleotide level; neither succinate nor cytochrome c oxidation is affected. The monitoring of the redox state of intramitochondrial pyridine nucleotides provides even more discrete localization of the inhibitory site of X-537A in electron transfer. Exposure of mitochondria to the antibiotic results in an increase of the rate and extent of oxidation of reduced pyridine nucleotides. Upon addition of glutamate or isocitrate and rotenone, X-537A decreases the rate of reduction of pyridine nucleotides. Specific analyses for pyridine nucleotides show that only the reduction of NADP+ is inhibited by X-537A. The most unusual aspect of the effect of the antibiotic is its specificity for the reduction of NADP+, identifying both glutamate and isocitrate as NADP+-requiring substrates in liver mitochondria. It was postulated earlier (7) that NADP+ is probably the real mitochondrial coenzyme of glutamate de- 
